MLchartDataset catalogue

autologous CAR T cells RD14-01

Term · Oncology and biomedicine · MLC-T-ONC-011522

A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) that targets an as of yet unidentified tumor-associated antigen (TAA), with potential immunomodulatory and antineoplastic activities. Upon administration of autologous CAR T cells RD14-01, the T cells target, bind to and induce selective cytotoxicity in tumor cells expressing the TAA.

Table 1. Record
IdentifierMLC-T-ONC-011522
FieldOncology and biomedicine
Synonymsautologous CAR-T cells RD14-01
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011522",
  "term": "autologous CAR T cells RD14-01",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) that targets an as of yet unidentified tumor-associated antigen (TAA), with potential immunomodulatory and antineoplastic activities. Upon administration of autologous CAR T cells RD14-01, the T cells target, bind to and induce selective cytotoxicity in tumor cells expressing the TAA.",
  "synonyms": [
    "autologous CAR-T cells RD14-01"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-car-t-cells-rd14-01/"
}

Record 2,856 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.